Skip to content
Screener

EPS (Diluted) at other companies

Humana logo
HumanaHUM
$5.73+27.1%
CVS Health logo
CVS HealthCVS
$2.31+189%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.04+61.5%
Astrana Health logo
Astrana HealthASTH
$0.29+107%
Agilon Health logo
Agilon HealthAGL
$1.04+116%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$0.05

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.49B+227%
Enterprise value$1.49B+202%
P/S1.6×+1.0×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026.

Filed
May 7, 2026, 8:00 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001834376-26-000022
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Nine Months Ended March 31, 2026Nine Months Ended March 31, 2025
Provision for Income Taxes167721,065509
Net Loss(29,940)(11,133)(10,466)(30,334)
Less: net income (loss) attributable to noncontrolling interests(479)245358(806)
Net Loss Attributable to InnovAge Holding Corp.$(29,461)$(11,378)$(10,824)$(29,528)
Weighted-average number of common shares outstanding - basic135,704,645135,200,314135,660,769135,471,907
Weighted-average number of common shares outstanding - diluted135,704,645135,200,314135,660,769135,471,907
Net loss per share - basic$(0.22)$(0.08)$(0.08)$(0.22)
Net loss per share - diluted$(0.22)$(0.08)$(0.08)$(0.22)

Item 1. Financial Statements (Unaudited)

FAQ

What is InnovAge Holdings, Inc.'s EPS (diluted)?
InnovAge Holdings, Inc. (INNV) reported EPS (diluted) of -$0.22 in Q1 2026.
How has InnovAge Holdings, Inc.'s EPS (diluted) changed year-over-year?
InnovAge Holdings, Inc.'s EPS (diluted) decreased by 175.0% year-over-year, from -$0.08 to -$0.22.
What is the long-term trend for InnovAge Holdings, Inc.'s EPS (diluted)?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s EPS (diluted) has grown at a 63.9% compound annual growth rate (CAGR), from -$0.05 to -$0.22.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about InnovAge Holdings, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude